全文预览

《咨询公司Casebook》Kellogs_Cases

上传者:非学无以广才 |  格式:pdf  |  页数:72 |  大小:398KB

文档介绍
epressant ??Develop a new drug in other segment Own R&D capabilities/resources Look for partnerships Myself: As a “cash-cow”, Eli Lilly should consider “milk” this product, extracting earnings as long as the product survives in the market. The first alternative to that would be to extend Prozac’s life cycle as long as possible. That could be achieved, for example, by prolonging Prozac’s patent protection. Interviewer: But how could that be achieved? Myself: Honestly, I’m not very familiar with the mechanisms through which a patent can be extended. Having said that, I would imagine there might be a legal mechanism to do that… And this issue brings us to one of my other points. There have to be a way to prolong Prozac’s life cycle and/or expand its user base. Lobbying might be a valid

收藏

分享

举报
下载此文档